Advanced Therapy Medicinal Products Global Market Report 2025
상품코드:1810821
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
첨단 치료제 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 19.4%로 1,044억 3,000만 달러로 성장할 것입니다. 예측 기간의 성장은 맞춤형 의료 및 정밀의료에 대한 수요 증가, 키메라 항원 수용체 T 세포 치료 및 유전자 편집 치료 파이프라인의 증가, 정밀의료 및 유전체학 도입 확대, 신흥 시장에서의 헬스케어 지출 증가, 분산형 임상시험 모델에 대한 관심 증가 등에 기인하는 것으로 분석됩니다. 예측 기간 동안 주요 동향으로는 동종 기성품 치료제 개발, 비바이러스 유전자 도입 벡터의 발전, 치료 시뮬레이션의 디지털 트윈 통합, 공급망 추적에 블록체인 도입, 조직공학을 위한 3D 바이오프린팅의 혁신 등이 있습니다.
맞춤형 의료에 대한 수요 증가는 향후 몇 년 동안 첨단 치료제 시장의 성장을 촉진할 것으로 예상됩니다. 맞춤형 의료는 개인별 유전자 프로필, 생활습관, 환경에 따라 치료 및 예방 전략을 맞춤화하는 헬스케어 접근법입니다. 이러한 수요 증가는 만성질환의 확산에 따른 것으로, 맞춤형 치료가 환자의 예후를 개선하고 부작용을 최소화할 수 있기 때문입니다. 첨단 치료제는 유전자 치료, 세포 치료, 조직공학치료 등 환자 개개인의 유전적, 생물학적 특성을 타겟으로 한 맞춤형 치료를 제공함으로써 맞춤형 의료를 지원합니다. 2024년 2월, 미국 비영리단체인 개인맞춤의료연합(Personalized Medicine Coalition)은 FDA가 2023년 희귀질환 환자를 위한 16개의 새로운 맞춤형 치료제를 승인했으며, 이는 2022년 6개에서 증가했다고 보고했습니다. 이 승인에는 7개의 항암제와 3개의 다른 질병 및 증상에 대한 치료법도 포함되어 있습니다. 이처럼 맞춤형 의료에 대한 수요 증가는 첨단 치료제 시장 확대에 박차를 가하고 있습니다.
첨단 치료제 시장의 주요 기업들은 암 및 기타 중증 질환의 치료 성과를 높이기 위해 새로운 CAR-T 세포 치료와 같은 혁신적인 치료법에 집중하고 있습니다. CAR-T 세포 치료는 암세포를 식별하고 파괴하도록 유전자 변형된 환자 자신의 T세포를 사용하는 첨단 암 치료법입니다. 예를 들어, 2022년 5월 스위스 제약사 노바티스(Novartis AG)는 두 가지 이상의 전신 치료 경험이 있는 재발성 또는 난치성 여포성 림프종(FL) 성인 환자를 위한 CAR-T 세포 치료제인 킴리아(Kymriah)의 FDA 승인을 획득했습니다. 이 치료법은 환자의 T세포가 CD19 단백질을 표적으로 하는 키메라 항원 수용체(CAR)를 발현하도록 유전공학적으로 조작하여 T세포가 악성 B세포를 인식하고 제거할 수 있도록 하는 치료법입니다. 또한, Kymriah는 4-1BB 코스티뮬레이트리 도메인을 함유하고 있어 T세포의 증식 및 지속을 지원하여 1회 투약으로 항종양 효과가 장기간 지속됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 첨단 치료제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 첨단 치료제 시장 : 성장률 분석
세계의 첨단 치료제 시장 실적 : 규모와 성장, 2019-2024
세계의 첨단 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 첨단 치료제 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 첨단 치료제 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
체세포 요법 의약품
조직공학 의약품
유전자 치료 의약품
세계의 첨단 치료제 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
유전자 편집 기술
바이러스 벡터 기술
줄기세포 기술
자동화와 인공지능 주도 프로세스
세계의 첨단 치료제 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
근 디스트로피
알츠하이머병
혈우병
낭포성섬유증
기타 용도
세계의 첨단 치료제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 첨단 치료제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
기타 최종사용자
세계의 첨단 치료제 시장 : 하위 세분화 체세포 요법 의약품(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
자가 세포 치료
동종 세포 치료
줄기세포 치료
수지상세포 요법
자연살해세포 요법
세계의 첨단 치료제 시장 : 하위 세분화 조직공학 의약품(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
자가 조직공학 제품
동종 조직공학 제품
비계 기반 조직공학
스캐폴드 프리 조직공학
피부 대체품
세계의 첨단 치료제 시장 : 하위 세분화 유전자 치료 의약품(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
생체내 유전자 치료
체외 유전자 치료
바이러스 벡터를 이용한 유전자 치료
비바이러스 벡터 기반 유전자 치료
유전자 편집 요법
제7장 지역별·국가별 분석
세계의 첨단 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 첨단 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
첨단 치료제 시장 : 경쟁 구도
첨단 치료제 시장 : 기업 개요
F. Hoffmann-La Roche Limited. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis
Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Catalent Inc.
BioMarin Pharmaceutical Inc.
AGC Biologics Inc.
ViaCyte Inc.
Rentschler Biopharma SE
JCR Pharmaceuticals Co. Ltd.
Vericel Corporation
UniQure N.V.
Fate Therapeutics Inc.
WuXi Advanced Therapies Inc.
Celonic Group AG
Pharmicell Co. Ltd.
Magenta Therapeutics Inc
MEDIPOST Co. Ltd.
Kolon TissueGene Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
첨단 치료제 시장 2029 : 새로운 기회를 제공하는 국가
첨단 치료제 시장 2029 : 새로운 기회를 제공하는 부문
첨단 치료제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Advanced therapy medicinal products are medicines derived from genes, cells, or tissue engineering that provide innovative treatments for a variety of diseases and injuries. These therapies function by repairing, replacing, or regenerating human cells, tissues, or organs to restore normal function.
The main types of advanced therapy medicinal products include somatic cell therapy medicinal products, tissue-engineered medicinal products, and gene therapy medicinal products. Somatic cell therapy medicinal products involve treatments using cells from the human body (excluding reproductive cells) that are manipulated or processed to treat, prevent, or cure diseases by repairing or replacing damaged tissues or cells. These therapies employ various technologies such as gene editing, viral vector technology, stem cell technology, and automation and artificial intelligence-driven processes. They are used in treating conditions including muscular dystrophies, Alzheimer's, hemophilia, cystic fibrosis, among others. Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, serving a wide range of end users such as hospitals, specialty clinics, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The advanced therapy medicinal products market research report is one of a series of new reports from The Business Research Company that provides advanced therapy medicinal products market statistics, including advanced therapy medicinal products global market size, regional shares, competitors with advanced therapy medicinal products market share, detailed advanced therapy medicinal products market segments, market trends and opportunities, and any further data you may need to thrive in the advanced therapy medicinal products industry. The advanced therapy medicinal products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The advanced therapy medicinal products market size has grown rapidly in recent years. It will grow from $42.85 billion in 2024 to $51.34 billion in 2025 at a compound annual growth rate (CAGR) of 19.8%. The growth during the historic period can be attributed to the increasing number of clinical trials for gene and cell therapies, the rising incidence of rare and genetic disorders, growing demand for curative treatments rather than chronic disease management, improving success rates of early-phase clinical studies, and the increasing prevalence of chronic and age-related conditions.
The advanced therapy medicinal products market size is expected to see rapid growth in the next few years. It will grow to $104.43 billion in 2029 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to the increasing demand for personalized and precision medicine approaches, a rising pipeline of chimeric antigen receptor T-cell and gene-editing therapies, growing adoption of precision medicine and genomics, increasing healthcare expenditure in emerging markets, and a heightened focus on decentralized clinical trial models. Key trends during the forecast period include the development of allogeneic off-the-shelf therapies, advancements in non-viral gene delivery vectors, integration of digital twins in therapy simulation, implementation of blockchain in supply chain tracking, and innovations in 3D bioprinting for tissue engineering.
The increasing demand for personalized medicine is anticipated to drive the growth of the advanced therapy medicinal products market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and prevention strategies based on an individual's unique genetic profile, lifestyle, and environment. This rising demand is largely due to the growing prevalence of chronic diseases, as personalized treatments improve patient outcomes and minimize side effects. Advanced therapy medicinal products support personalized medicine by providing tailored treatments such as gene, cell, and tissue-engineered therapies that specifically target the unique genetic and biological characteristics of individual patients. In February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals also included seven cancer drugs and three treatments for other diseases and conditions. Thus, the growing demand for personalized medicine is fueling the expansion of the advanced therapy medicinal products market.
Key players in the advanced therapy medicinal products market are concentrating on innovative therapies like new CAR-T cell therapies to enhance treatment outcomes for cancer and other severe diseases. CAR-T cell therapies are advanced cancer treatments that use a patient's own T cells, genetically modified to identify and destroy cancer cells. For example, in May 2022, Novartis AG, a Switzerland-based pharmaceutical company, received FDA approval for Kymriah, a CAR-T cell therapy intended for adult patients with relapsed or refractory follicular lymphoma (FL) after two or more prior systemic therapies. This treatment involves genetically engineering the patient's T cells to express a chimeric antigen receptor (CAR) that targets the CD19 protein, enabling the T cells to recognize and eliminate malignant B cells. Kymriah also includes a 4-1BB costimulatory domain, which supports T cell expansion and persistence, resulting in prolonged antitumor effects from a single infusion.
In May 2024, Tri-Tech Forensics Inc., a US-based forensic company, acquired SAM Medical Products for an undisclosed sum. This acquisition is expected to help Tri-Tech Forensics broaden its emergency medical product portfolio and reinforce its market position. SAM Medical Products is a US-based firm specializing in the development, manufacturing, and marketing of orthopedic splints, wound care devices, and medical service products designed for various healthcare professionals.
Major players in the advanced therapy medicinal products market are F. Hoffmann-La Roche Limited., Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited., Lonza Group AG, Catalent Inc., BioMarin Pharmaceutical Inc., AGC Biologics Inc., ViaCyte Inc., Rentschler Biopharma SE, JCR Pharmaceuticals Co. Ltd., Vericel Corporation, UniQure N.V., Fate Therapeutics Inc., WuXi Advanced Therapies Inc., Celonic Group AG, Pharmicell Co. Ltd., Magenta Therapeutics Inc, MEDIPOST Co. Ltd., and Kolon TissueGene Inc.
North America was the largest region in the advanced therapy medicinal products market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in advanced therapy medicinal products report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the advanced therapy medicinal products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The advanced therapy medicinal products market consists of revenues earned by entities by providing services such as cell and gene therapy development services, viral vector production and characterization, regulatory and clinical trial support, analytical testing and quality control services, and process development and scale-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced therapy medicinal products market also includes sales of gene therapy vectors, engineered tissue scaffolds, bioengineered skin substitutes, and encapsulated cell therapies. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Advanced Therapy Medicinal Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on advanced therapy medicinal products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for advanced therapy medicinal products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The advanced therapy medicinal products market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3) By Gene Therapy Medicinal Products: In Vivo Gene Therapy; Ex Vivo Gene Therapy; Viral Vector-Based Gene Therapy; Non-Viral Vector-Based Gene Therapy; Gene Editing Therapies
3. Advanced Therapy Medicinal Products Market Trends And Strategies
4. Advanced Therapy Medicinal Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Advanced Therapy Medicinal Products Growth Analysis And Strategic Analysis Framework
5.1. Global Advanced Therapy Medicinal Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Advanced Therapy Medicinal Products Market Growth Rate Analysis
5.4. Global Advanced Therapy Medicinal Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Advanced Therapy Medicinal Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Advanced Therapy Medicinal Products Total Addressable Market (TAM)
6.1. Global Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Somatic Cell Therapy Medicinal Products
Tissue Engineered Medicinal Products
Gene Therapy Medicinal Products
6.2. Global Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Editing Technologies
Viral Vector Technology
Stem Cell Technology
Automation And Artificial Intelligence-Driven Processes
6.3. Global Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Muscular Dystrophies
Alzheimer's
Hemophilia
Cystic Fibrosis
Other Applications
6.4. Global Advanced Therapy Medicinal Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Advanced Therapy Medicinal Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End Users
6.6. Global Advanced Therapy Medicinal Products Market, Sub-Segmentation Of Somatic Cell Therapy Medicinal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Cell Therapy
Allogeneic Cell Therapy
Stem Cell Therapy
Dendritic Cell Therapy
Natural Killer Cell Therapy
6.7. Global Advanced Therapy Medicinal Products Market, Sub-Segmentation Of Tissue Engineered Medicinal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Tissue-Engineered Products
Allogeneic Tissue-Engineered Products
Scaffold-Based Tissue Engineering
Scaffold-Free Tissue Engineering
Skin Substitutes
6.8. Global Advanced Therapy Medicinal Products Market, Sub-Segmentation Of Gene Therapy Medicinal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In Vivo Gene Therapy
Ex Vivo Gene Therapy
Viral Vector-Based Gene Therapy
Non-Viral Vector-Based Gene Therapy
Gene Editing Therapies
7. Advanced Therapy Medicinal Products Market Regional And Country Analysis
7.1. Global Advanced Therapy Medicinal Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Advanced Therapy Medicinal Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Advanced Therapy Medicinal Products Market
9.1. China Advanced Therapy Medicinal Products Market Overview
9.2. China Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Advanced Therapy Medicinal Products Market
10.1. India Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Advanced Therapy Medicinal Products Market
11.1. Japan Advanced Therapy Medicinal Products Market Overview
11.2. Japan Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Advanced Therapy Medicinal Products Market
12.1. Australia Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Advanced Therapy Medicinal Products Market
13.1. Indonesia Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Advanced Therapy Medicinal Products Market
14.1. South Korea Advanced Therapy Medicinal Products Market Overview
14.2. South Korea Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Advanced Therapy Medicinal Products Market
15.1. Western Europe Advanced Therapy Medicinal Products Market Overview
15.2. Western Europe Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Advanced Therapy Medicinal Products Market
16.1. UK Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Advanced Therapy Medicinal Products Market
21.1. Eastern Europe Advanced Therapy Medicinal Products Market Overview
21.2. Eastern Europe Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Advanced Therapy Medicinal Products Market
22.1. Russia Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Advanced Therapy Medicinal Products Market
23.1. North America Advanced Therapy Medicinal Products Market Overview
23.2. North America Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Advanced Therapy Medicinal Products Market
24.1. USA Advanced Therapy Medicinal Products Market Overview
24.2. USA Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Advanced Therapy Medicinal Products Market
26.1. South America Advanced Therapy Medicinal Products Market Overview
26.2. South America Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Advanced Therapy Medicinal Products Market
27.1. Brazil Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Advanced Therapy Medicinal Products Market
28.1. Middle East Advanced Therapy Medicinal Products Market Overview
28.2. Middle East Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Advanced Therapy Medicinal Products Market
29.1. Africa Advanced Therapy Medicinal Products Market Overview
29.2. Africa Advanced Therapy Medicinal Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Advanced Therapy Medicinal Products Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Advanced Therapy Medicinal Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Advanced Therapy Medicinal Products Market Competitive Landscape And Company Profiles
